News
Dr. Davis closed his message by expressing hope and confidence in the future-both for the graduating class of 2025 and for ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...
Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...
Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...
Kidney disease ranges from mild dysfunction treatable with medication to severe cases requiring dialysis or transplant. Acute ...
NGO, Enterprise Group PLC, Volta River Authority (VRA), National Petroleum Authority (NPA), Kalmoni Foundation, Revna ...
11h
ABP News on MSNAdvancing Nephropathology — The Role Of Modern Diagnostics In Chronic Kidney Disease ManagementAdvancing Chronic kidney disease care in India hinges on integrating modern diagnostics from early biomarker screening to ...
The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.
We can take simple steps to radically increase the number of kidneys available for transplant, but political inertia has ...
2d
GlobalData on MSNNovartis to strengthen renal disease portfolio with RegulusNovartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results